S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$19.55
-0.8%
$19.81
$16.21
$26.22
N/A0.976,028 shs15,309 shs
InMode Ltd. stock logo
INMD
InMode
$17.45
-1.0%
$21.32
$17.29
$48.25
$1.47B2.161.60 million shs946,515 shs
LivaNova PLC stock logo
LIVN
LivaNova
$51.87
-2.5%
$53.51
$42.75
$59.86
$2.80B0.89610,994 shs484,959 shs
Natus Medical Incorporated stock logo
NTUS
Natus Medical
$32.96
$32.96
$20.90
$33.93
$1.14B0.22325,002 shs1,514 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
+1.08%-3.62%-4.32%-6.46%-20.96%
InMode Ltd. stock logo
INMD
InMode
-0.40%-4.40%-15.73%-19.47%-52.13%
LivaNova PLC stock logo
LIVN
LivaNova
-0.36%-4.76%+5.10%+5.45%+10.79%
Natus Medical Incorporated stock logo
NTUS
Natus Medical
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
InMode Ltd. stock logo
INMD
InMode
3.0692 of 5 stars
3.23.00.00.02.31.72.5
LivaNova PLC stock logo
LIVN
LivaNova
1.2498 of 5 stars
2.23.00.00.00.91.71.9
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
2.33
HoldN/AN/A
InMode Ltd. stock logo
INMD
InMode
2.33
Hold$32.8087.97% Upside
LivaNova PLC stock logo
LIVN
LivaNova
2.40
Hold$64.4024.16% Upside
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/AN/AN/AN/A

Current Analyst Ratings

Latest GNGBY, LIVN, INMD, and NTUS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/12/2024
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$34.00 ➝ $33.00
4/9/2024
InMode Ltd. stock logo
INMD
InMode
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
3/27/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
3/20/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$72.00
2/26/2024
LivaNova PLC stock logo
LIVN
LivaNova
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$57.00 ➝ $61.00
2/22/2024
LivaNova PLC stock logo
LIVN
LivaNova
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$56.00 ➝ $62.00
2/21/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$62.00 ➝ $72.00
2/20/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00 ➝ $70.00
2/15/2024
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$32.00 ➝ $34.00
2/14/2024
InMode Ltd. stock logo
INMD
InMode
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $26.00
1/18/2024
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$33.00 ➝ $32.00
(Data available from 4/17/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$3.00BN/A$1.60 per share12.21$10.53 per shareN/A
InMode Ltd. stock logo
INMD
InMode
$492.05M2.98$2.18 per share8.00$6.68 per share2.61
LivaNova PLC stock logo
LIVN
LivaNova
$1.15B2.43$4.18 per share12.40$23.72 per share2.19
Natus Medical Incorporated stock logo
NTUS
Natus Medical
$473.44M2.41$2.02 per share16.34$12.44 per share2.65

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$227.45M$0.8423.27N/A7.58%8.05%4.76%N/A
InMode Ltd. stock logo
INMD
InMode
$197.92M$2.307.597.93N/A40.22%29.80%27.02%5/2/2024 (Confirmed)
LivaNova PLC stock logo
LIVN
LivaNova
$17.55M$0.32162.1015.48N/A1.53%12.23%6.47%5/1/2024 (Confirmed)
Natus Medical Incorporated stock logo
NTUS
Natus Medical
$13.18M$0.3789.0820.99N/A2.65%10.15%7.65%N/A

Latest GNGBY, LIVN, INMD, and NTUS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
InMode Ltd. stock logo
INMD
InMode
$0.40N/A-$0.40N/AN/AN/A  
5/1/2024N/A
LivaNova PLC stock logo
LIVN
LivaNova
$0.47N/A-$0.47N/AN/AN/A  
2/21/202412/31/2023
LivaNova PLC stock logo
LIVN
LivaNova
$0.77$0.87+$0.10$1.44$287.65 million$310.10 million    
2/13/202412/31/2023
InMode Ltd. stock logo
INMD
InMode
$0.66$0.71+$0.05$0.64$124.77 million$126.80 million    
2/1/2024Q4 2023
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A$0.29+$0.29$0.33N/A$930.96 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$0.301.53%N/A35.71%N/A
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/AN/AN/AN/AN/A

Latest GNGBY, LIVN, INMD, and NTUS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/24/2024
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$0.41644/23/20244/24/20245/14/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
0.92
0.56
InMode Ltd. stock logo
INMD
InMode
N/A
12.51
11.87
LivaNova PLC stock logo
LIVN
LivaNova
0.44
2.95
2.51
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/A
2.54
1.90

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
InMode Ltd. stock logo
INMD
InMode
68.04%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Natus Medical Incorporated stock logo
NTUS
Natus Medical
92.35%

Insider Ownership

CompanyInsider Ownership
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
InMode Ltd. stock logo
INMD
InMode
6.92%
LivaNova PLC stock logo
LIVN
LivaNova
0.19%
Natus Medical Incorporated stock logo
NTUS
Natus Medical
1.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
11,082N/AN/ANot Optionable
InMode Ltd. stock logo
INMD
InMode
58183.98 million78.17 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90053.96 million53.85 millionOptionable
Natus Medical Incorporated stock logo
NTUS
Natus Medical
1,40034.58 million34.17 millionOptionable

GNGBY, LIVN, INMD, and NTUS Headlines

SourceHeadline
Natus Neuro taps Philips, Medtronic veteran as CEONatus Neuro taps Philips, Medtronic veteran as CEO
massdevice.com - March 6 at 7:54 PM
Route 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial OfficerRoute 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial Officer
finance.yahoo.com - September 18 at 9:10 AM
What causes an increase in belly fat?What causes an increase in belly fat?
medicalnewstoday.com - August 24 at 5:08 PM
ADHD / ADDADHD / ADD
medicalnewstoday.com - August 16 at 9:20 PM
Natus Medical IncorporatedNatus Medical Incorporated
thestreet.com - July 14 at 9:58 AM
ICU Monitor Market Expected Growth, Demand and Trends for 2030 | Natus Medical, Comen, Micromed, Nihon Kohden Corp.ICU Monitor Market Expected Growth, Demand and Trends for 2030 | Natus Medical, Comen, Micromed, Nihon Kohden Corp.
marketwatch.com - May 12 at 10:30 PM
Jamie Foxx is reportedly stable and recovering: What we know about his medical complicationJamie Foxx is reportedly 'stable' and 'recovering': What we know about his 'medical complication'
yahoo.com - May 9 at 11:07 PM
BCI and EEG Market 2023 by Sales, Share, Growth Opportunity with Top Players are Medtronic, Natus Medical, Nihon Kohden, NeuroPace IncBCI and EEG Market 2023 by Sales, Share, Growth Opportunity with Top Players are Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc
marketwatch.com - May 5 at 11:46 AM
Brain Mapping Instruments Market Outlook and Forecast to 2030 | GE Healthcare, Philips Healthcare, Siemens Healthcare, Natus MedicalBrain Mapping Instruments Market Outlook and Forecast to 2030 | GE Healthcare, Philips Healthcare, Siemens Healthcare, Natus Medical
marketwatch.com - May 5 at 11:46 AM
Neonatal Hearing Screening Devices Market Trends Analysis And Research Report to 2029 – Natus Medical, Hill-Rom, MAICO DiagnosticsNeonatal Hearing Screening Devices Market Trends Analysis And Research Report to 2029 – Natus Medical, Hill-Rom, MAICO Diagnostics
marketwatch.com - May 4 at 11:51 PM
Polysomnography Software Market Outlook 2023 and Future Forecast to 2030 | SOMNOmedics, custo med, Cadwell Industries, Natus Medical IncorporatedPolysomnography Software Market Outlook 2023 and Future Forecast to 2030 | SOMNOmedics, custo med, Cadwell Industries, Natus Medical Incorporated
marketwatch.com - April 9 at 8:45 PM
Sleep Apnea Device Market Size, Share, Growth, Trends, Analysis to 2029Sleep Apnea Device Market Size, Share, Growth, Trends, Analysis to 2029
marketwatch.com - March 19 at 10:47 PM
Natus Medical completes acquisition deal with MicromedNatus Medical completes acquisition deal with Micromed
pharmabiz.com - January 19 at 10:35 PM
Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SASNatus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS
finance.yahoo.com - January 18 at 10:03 AM
Natus Medical closes acquisition of MicromedNatus Medical closes acquisition of Micromed
massdevice.com - January 18 at 10:03 AM
Italy: Natus Medical to acquire Micromed in first transaction since ArchiMed purchaseItaly: Natus Medical to acquire Micromed in first transaction since ArchiMed purchase
laingbuissonnews.com - January 3 at 7:26 AM
Epidemiology News and ResearchEpidemiology News and Research
news-medical.net - October 14 at 12:36 PM
Novanta Set to Join S&P MidCap 400; Six Flags Entertainment to Join S&P SmallCap 600Novanta Set to Join S&P MidCap 400; Six Flags Entertainment to Join S&P SmallCap 600
finance.yahoo.com - July 21 at 7:03 PM
ArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity valueArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity value
finance.yahoo.com - July 21 at 2:03 PM
Natus Medical Enters Oversold Territory (NTUS)Natus Medical Enters Oversold Territory (NTUS)
nasdaq.com - June 14 at 7:18 PM
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates TREC, CVET, NTUSSHAREHOLDER ALERT: Halper Sadeh LLP Investigates TREC, CVET, NTUS
apnews.com - June 7 at 6:15 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NTUS, ACC, KCACSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NTUS, ACC, KCAC
stockhouse.com - May 13 at 3:28 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NTUS, ACC, SIMO, PLANSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NTUS, ACC, SIMO, PLAN
apnews.com - May 9 at 2:01 PM
NATUS MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in ProposeNATUS MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Propose
us.acrofan.com - May 6 at 12:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Getinge AB (publ) logo

Getinge AB (publ)

OTCMKTS:GNGBY
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; monitoring systems, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected devices, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; pressure controlling syringes, vessel harvesting systems, balloon expandable covered stents, tubing sets, hemoconcentrators, and lung machines; and OR integration and management. In addition, it offers extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport and storage; trays and baskets; vascular and cardiothoracic surgery solutions; sterilizer loading equipment; and cage handing systems. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
InMode logo

InMode

NASDAQ:INMD
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
LivaNova logo

LivaNova

NASDAQ:LIVN
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Natus Medical logo

Natus Medical

NASDAQ:NTUS
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.